- Home
- KNDI vs HLVX Comparison
KNDI vs HLVX Comparison
Compare KNDI & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- HLVX
- Stock Information
- Founded
- KNDI 2002
- HLVX 2020
- Country
- KNDI China
- HLVX United States
- Employees
- KNDI N/A
- HLVX N/A
- Industry
- KNDI Auto Manufacturing
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- KNDI Consumer Discretionary
- HLVX Health Care
- Exchange
- KNDI Nasdaq
- HLVX Nasdaq
- Market Cap
- KNDI 91.2M
- HLVX 93.1M
- IPO Year
- KNDI N/A
- HLVX 2022
- Fundamental
- Price
- KNDI $1.06
- HLVX $1.88
- Analyst Decision
- KNDI
- HLVX Hold
- Analyst Count
- KNDI 0
- HLVX 5
- Target Price
- KNDI N/A
- HLVX $2.33
- AVG Volume (30 Days)
- KNDI 137.7K
- HLVX 194.1K
- Earning Date
- KNDI 03-13-2025
- HLVX 03-19-2025
- Dividend Yield
- KNDI N/A
- HLVX N/A
- EPS Growth
- KNDI N/A
- HLVX N/A
- EPS
- KNDI N/A
- HLVX N/A
- Revenue
- KNDI $118,127,232.00
- HLVX N/A
- Revenue This Year
- KNDI N/A
- HLVX N/A
- Revenue Next Year
- KNDI N/A
- HLVX N/A
- P/E Ratio
- KNDI N/A
- HLVX N/A
- Revenue Growth
- KNDI N/A
- HLVX N/A
- 52 Week Low
- KNDI $0.89
- HLVX $1.55
- 52 Week High
- KNDI $2.98
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- KNDI 46.47
- HLVX 43.15
- Support Level
- KNDI $1.03
- HLVX $1.92
- Resistance Level
- KNDI $1.20
- HLVX $2.00
- Average True Range (ATR)
- KNDI 0.07
- HLVX 0.07
- MACD
- KNDI -0.01
- HLVX -0.01
- Stochastic Oscillator
- KNDI 11.54
- HLVX 18.07
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.